THE US Food and Drug
Administration has issued new
dosing guidance for children using
valganciclovir (Valcyte) oral tablets
and solutions used by children and
adolescents receiving a kidney or
heart transplant.
The change aims to prevent drug
overdosing of children with low
body weight, low body surface area
and very low serum creatnine.
Revised instructions now appear
in the product’s label, and include
an upper limit on “calculated
creatinine clearance”.
Valcyte is an antiviral used for the
prevention of cytomegalovirus
(CMV) disease which can cause
pneumonia or colitis in people with
weakened immune systems.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Sep 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Sep 10
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.